Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,871 | 250 | 81.9% |
| Education | $481.24 | 8 | 8.1% |
| Gift | $447.59 | 1 | 7.5% |
| Travel and Lodging | $145.77 | 1 | 2.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | $894.76 | 35 | $0 (2024) |
| Astellas Pharma US Inc | $794.22 | 41 | $0 (2024) |
| PFIZER INC. | $771.74 | 41 | $0 (2024) |
| ABBVIE INC. | $621.08 | 32 | $0 (2024) |
| NxThera, Inc. | $548.21 | 10 | $0 (2018) |
| Dendreon Pharmaceuticals LLC | $405.82 | 23 | $0 (2024) |
| NeoTract Inc. | $319.08 | 10 | $0 (2020) |
| Janssen Biotech, Inc. | $287.28 | 11 | $0 (2024) |
| Teleflex LLC | $203.07 | 8 | $0 (2024) |
| 180 Medical, Inc. | $117.59 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $451.40 | 22 | Bayer Healthcare Pharmaceuticals Inc. ($99.86) |
| 2023 | $649.71 | 26 | PFIZER INC. ($114.50) |
| 2022 | $816.25 | 33 | Bayer HealthCare Pharmaceuticals Inc. ($224.98) |
| 2021 | $455.72 | 22 | Bayer HealthCare Pharmaceuticals Inc. ($170.20) |
| 2020 | $782.92 | 33 | NeoTract Inc. ($234.55) |
| 2019 | $617.82 | 32 | PFIZER INC. ($157.79) |
| 2018 | $767.57 | 36 | PFIZER INC. ($183.22) |
| 2017 | $1,404 | 56 | NxThera, Inc. ($510.02) |
All Payment Transactions
260 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 10/22/2024 | Ferring Pharmaceuticals Inc. | ADSTILADRIN (Biological) | Food and Beverage | In-kind items and services | $28.93 | General |
| Category: ONCOLOGY | ||||||
| 10/15/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $21.87 | General |
| Category: Oncology | ||||||
| 10/02/2024 | Endo USA, Inc. | XIAFLEX (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: UROLOGY | ||||||
| 10/02/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: HORMONE THERAPY | ||||||
| 10/01/2024 | Teleflex LLC | UROLIFT (Device) | Food and Beverage | In-kind items and services | $20.64 | General |
| Category: INTERVENTIONAL UROLOGY | ||||||
| 09/24/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 09/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Oncology | ||||||
| 09/09/2024 | Janssen Biotech, Inc. | ERLEADA (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Oncology | ||||||
| 08/22/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: ONCOLOGY | ||||||
| 08/21/2024 | Bayer Healthcare Pharmaceuticals Inc. | Xofigo (Drug), Nubeqa | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Oncology | ||||||
| 08/01/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Oncology | ||||||
| 07/11/2024 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Oncology | ||||||
| 06/18/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $25.15 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 04/29/2024 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
| 04/24/2024 | Astellas Pharma US Inc | Xtandi (Drug) | Food and Beverage | In-kind items and services | $14.78 | General |
| Category: Oncology | ||||||
| 04/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $23.41 | General |
| Category: Oncology | ||||||
| 04/11/2024 | PFIZER INC. | XTANDI (Drug), ORGOVYX, TALZENNA | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: ONCOLOGY | ||||||
| 04/02/2024 | 180 Medical, Inc. | — | Food and Beverage | In-kind items and services | $14.50 | General |
| 03/21/2024 | Sumitomo Pharma America, Inc. | ORGOVYX (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: HORMONE THERAPY | ||||||
| 03/12/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.17 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/22/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: Oncology | ||||||
| 12/11/2023 | ACCORD HEALTHCARE, INC. | CAMCEVI (Drug) | Food and Beverage | In-kind items and services | $106.28 | General |
| Category: Oncology | ||||||
| 12/06/2023 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug), Xofigo | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Oncology | ||||||
| 12/05/2023 | Dendreon Pharmaceuticals LLC | PROVENGE (Drug) | Food and Beverage | In-kind items and services | $29.02 | General |
| Category: CELLULAR BIOLOGIC TREATMENT FOR PROSTATE CANCER | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 3,173 | 4,483 | $1.3M | $283,667 |
| 2022 | 20 | 3,523 | 8,356 | $1.1M | $277,532 |
| 2021 | 23 | 3,998 | 11,104 | $1.5M | $395,823 |
| 2020 | 23 | 3,528 | 4,903 | $1.1M | $275,363 |
All Medicare Procedures & Services
99 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 522 | 723 | $191,595 | $60,558 | 31.6% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Office | 2023 | 66 | 90 | $184,500 | $53,109 | 28.8% |
| 76770 | Complete ultrasound scan behind abdominal cavity | Office | 2023 | 387 | 429 | $118,404 | $35,232 | 29.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 408 | 494 | $88,920 | $28,652 | 32.2% |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | Office | 2023 | 22 | 198 | $297,000 | $23,587 | 7.9% |
| 52000 | Diagnostic exam of bladder and urethra using an endoscope | Office | 2023 | 106 | 129 | $93,756 | $22,791 | 24.3% |
| 50590 | Shock wave crushing of kidney stones | Facility | 2023 | 18 | 18 | $32,856 | $7,986 | 24.3% |
| 52356 | Crushing of stone of ureter with insertion of stent using an endoscope | Facility | 2023 | 15 | 18 | $19,760 | $5,691 | 28.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 62 | 62 | $16,430 | $4,811 | 29.3% |
| 76775 | Limited ultrasound scan behind abdominal cavity | Office | 2023 | 134 | 138 | $38,640 | $4,585 | 11.9% |
| 52353 | Crushing of stone of ureter using an endoscope | Facility | 2023 | 12 | 13 | $13,720 | $4,177 | 30.4% |
| 52281 | Dilation of urethra using an endoscope | Office | 2023 | 13 | 16 | $17,120 | $3,951 | 23.1% |
| 55700 | Biopsy of prostate gland | Office | 2023 | 19 | 19 | $18,240 | $3,456 | 18.9% |
| 51798 | Ultrasound measurement of bladder capacity after voiding | Office | 2023 | 366 | 461 | $21,206 | $3,276 | 15.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 30 | 32 | $10,752 | $3,133 | 29.1% |
| 52310 | Simple removal of foreign body, stone, or stent in urethra or bladder using an endoscope | Office | 2023 | 12 | 12 | $12,480 | $2,965 | 23.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 727 | 1,226 | $14,703 | $2,686 | 18.3% |
| 52332 | Insertion of stent in ureter using an endoscope | Facility | 2023 | 16 | 20 | $26,952 | $2,148 | 8.0% |
| 76872 | Ultrasound scan of pelvic region through rectum | Office | 2023 | 21 | 21 | $8,505 | $2,147 | 25.2% |
| 51702 | Simple insertion of temporary bladder tube | Office | 2023 | 19 | 39 | $5,967 | $1,552 | 26.0% |
| 55700 | Biopsy of prostate gland | Facility | 2023 | 18 | 19 | $18,240 | $1,492 | 8.2% |
| 52224 | Destruction of growth of bladder and urethra using an endoscope, less than 0.5 cm | Facility | 2023 | 11 | 11 | $22,550 | $1,471 | 6.5% |
| 74420 | Imaging of urinary tract following injection of a contrast agent | Facility | 2023 | 50 | 68 | $3,315 | $1,258 | 37.9% |
| 76870 | Ultrasound scan of scrotum | Office | 2023 | 11 | 12 | $2,364 | $808.22 | 34.2% |
| 96402 | Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | Office | 2023 | 23 | 35 | $2,765 | $782.70 | 28.3% |
About Dr. Lars Thompson, MD
Dr. Lars Thompson, MD is a Urology healthcare provider based in Canton, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1063511772.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lars Thompson, MD has received a total of $5,945 in payments from pharmaceutical and medical device companies, with $451.40 received in 2024. These payments were reported across 260 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($4,871).
As a Medicare-enrolled provider, Thompson has provided services to 14,222 Medicare beneficiaries, totaling 28,846 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 99 distinct procedure/service records.
Practice Information
- Specialty Urology
- Location Canton, NY
- Active Since 09/21/2006
- Last Updated 10/06/2022
- Taxonomy Code 208800000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063511772
Products in Payments
- XTANDI (Drug) $853.91
- Nubeqa (Drug) $584.18
- Rezum (Device) $548.21
- PROVENGE (Drug) $520.59
- UroLift (Device) $285.84
- Xofigo (Drug) $219.59
- LUPRON DEPOT (Drug) $202.41
- Xtandi (Drug) $194.47
- UROLIFT (Device) $165.28
- Myrbetriq (Drug) $154.12
- ERLEADA (Drug) $148.50
- Erleada (Drug) $131.92
- BOTOX (Biological) $128.54
- ACTHAR (Biological) $115.03
- Lupron Depot (Drug) $107.01
- CAMCEVI (Drug) $106.28
- ORGOVYX (Drug) $98.07
- Androgel (Drug) $96.05
- Adempas (Drug) $90.99
- Lupron (Drug) $87.07
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Urology Doctors in Canton
Carl Capelouto, M.d, M.D
Urology — Payments: $46,769
Dr. Yasin Bhanji, Md, MD
Urology — Payments: $16,581
Steven Ochs, Md, MD
Urology — Payments: $14,582
David Heiser, Md, MD
Urology — Payments: $6,710
Bechara Tabet, Md, MD
Urology — Payments: $6,110
Dr. Jeffrey Cerone, M.d, M.D
Urology — Payments: $5,706